The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients

Basaran, G.Saglam, S.Tansan, S.Demirel, M.Gokmen, E.Aktan, S.Goker, E.Kaban, K. K.Saip, P.Demir, G.Bavbek, S. E.Mandel, N. M.Tecimer, C.Turhal, N. S.Garipoglu, M.2019-10-272019-10-2720110732-183X1527-7755https://doi.org/10.1200/jco.2011.29.15_suppl.e11042https://hdl.handle.net/11454/44455en10.1200/jco.2011.29.15_suppl.e11042info:eu-repo/semantics/closedAccessThe impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patientsConference Object2915WOS:000208880303017Q1